CIK 0000880242 · Non-accelerated filer<br>Smaller reporting company
BIOLARGO, INC.
Sign in to watch- Ticker
- BLGO
- Exchange
- OTC
- Industry
- Chemicals & Allied Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650159115
- Phone
- 888 400-2863
- Business address
- 14921 CHESTNUT ST., WESTMINSTER, CA, 92683
- Former names
- NUWAY MEDICAL INC, NUWAY ENERGY INC, LATIN AMERICAN CASINOS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-31 | CALVERT DENNIS P President | Gift | −225,000 | 9,280,256 | ||
| 2020-12-31 | CALVERT DENNIS P President | Grant or award | +316,260 | $0.12 | $38K | 9,596,516 |
| 2020-10-08 | PROVENZANO JOSEPH L Secretary | Grant or award · Option to purchase common stock | +74,051 | 1,658,661 | ||
| 2020-10-08 | Marshall Dennis E Director | Grant or award · Option to purchase common stock | +37,500 | 2,914,104 | ||
| 2020-10-08 | DARGAN CHARLES K Chief Financial Officer | Grant or award · Option to purchase common stock | +2,500 | 3,610,786 | ||
| 2020-10-08 | DARGAN CHARLES K Chief Financial Officer | Grant or award · Option to purchase common stock | +50,000 | 3,460,786 | ||
| 2020-10-06 | CALVERT DENNIS P President | Grant or award | +164,331 | $0.15 | $25K | 9,505,256 |
| 2020-09-30 | DARGAN CHARLES K Chief Financial Officer | Grant or award · Option to purchase common stock | +5,000 | 3,618,286 | ||
| 2020-09-30 | CODE KENNETH REAY Chief Science Officer | Grant or award | +185,339 | $0.15 | $28K | 24,107,807 |
| 2020-09-30 | CALVERT DENNIS P President | Grant or award | +164,331 | $0.15 | $25K | 9,505,256 |
| 2020-09-30 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +100,000 | 1,886,933 | ||
| 2020-09-30 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +125,000 | 2,083,302 | ||
| 2020-09-30 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +100,000 | 767,609 | ||
| 2020-09-30 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +125,000 | 3,026,604 | ||
| 2020-06-30 | Marshall Dennis E Director | Grant or award · Option to purchase common stock | +2,500 | 2,894,104 | ||
| 2020-06-30 | DARGAN CHARLES K Chief Financial Officer | Grant or award · Option to purchase common stock | +5,000 | 3,633,286 | ||
| 2020-06-30 | CODE KENNETH REAY Chief Science Officer | Grant or award | +166,474 | $0.16 | $27K | 23,922,468 |
| 2020-06-30 | CALVERT DENNIS P President | Grant or award | +200,929 | $0.16 | $32K | 9,340,925 |
| 2020-06-30 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +93,750 | 1,786,933 | ||
| 2020-06-30 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +93,750 | 667,609 |
Page 9 of 12 · 228 trades